Communiqués Alfresa Holdings Corporation

Actions

2784

JP3126340003

Equipement, fournitures et distribution médicale

Marché Fermé - Japan Exchange Autres places de cotation 08:30:00 03/07/2026			Varia. 5j.	Varia. 1 janv.
2 178,00 ^JPY	+0,48%		+0,02%	-10,41%

15/05	Alfresa Holdings Corporation autorise un programme de rachat d'actions.	CI
15/05	Alfresa Holdings Corporation (TSE:2784) annonce un rachat d'actions portant sur 6'307'800 titres, soit 3.46% du capital, pour 14'999.95 millions de yens.	CI

Communiqués

20/05	Alfresa : Acquisition of ISMS Certification by GEKKA WORKS Co., Ltd. for Managing Provision of its Communication Service for Healthcare and Caregiving Professionals	PU
18/05	Alfresa : Notice on the Decision of Terms of the 1st Issuance of Stock Acquisition Right via Third-Party Allotment for Acquisition of Own Shares via Fully Committed Share Repurchase (Japanese ASR)	PU
18/05	Alfresa : Notice of the Result and Completion of the Acquisition of Own Shares through Off-Auction Own Share Repurchase Trading System(ToSTNeT-3)	PU
15/05	Alfresa : Briefing on Business Results for the Fiscal Year Ended March 2026 （2,633KB） PDF	PU
15/05	Alfresa : Notice Regarding Partial Amendments to the Articles of Incorporation	PU
15/05	Alfresa : Consolidated Financial Results for the Fiscal Year Ended March 31, 2026(Under Japanese GAAP)	PU
15/05	Alfresa : Financial Results Summary for the Fiscal Year Ended March 31, 2026	PU
15/05	Alfresa : Notice Regarding the Establishment of a Collaborative Research Laboratory in Clinical and Emerging Infectious Diseases at Hiroshima University Hospital Aimed at Strengthening Countermeasures for a Tick-Borne Infectious Disease Deepening Collaboration Between Industry and Academia to Advance Research and Education, Promote Implementation in Industry, and Contribute to Society	PU
28/04	Alfresa : Notice Regarding the Business Alliance Between Alfresa Healthcare Corporation and AdInte Co., Ltd. to Jointly Develop a Retail Media Business to Support the Sales Promotion Activities of Manufacturers and Retailers	PU
28/04	Alfresa : Conclusion of a Comprehensive Partnership Agreement Between Meisho Co., Ltd. and Komatsu City, Ishikawa Prefecture, to Promote the Health of and Realize Safe and Comfortable Lives for the City’s Residents	PU
31/03	Alfresa : Notice Regarding the Business Alliance Between Mwis Corporation and Ark Medical Solutions Inc. to Expand the Latter’s CRO Business	PU
31/03	Notice Regarding Achievement of ISO 9001 Certification by Subsidiaries:Efforts to Improve Logistics Quality in the Alfresa Group	PU
17/02	Alfresa : Conclusion of a Comprehensive Partnership Agreement Between Meisho Co., Ltd. and Tsuruga City to Promote the Health of and Realize Safe and Comfortable Lifestyles for the City’s Residents	PU
12/02	Alfresa : Notice Regarding the Release of neffy® 1 mg and neffy® 2 mg as Emergency Supportive Therapy to Suppress Anaphylaxis	PU
10/02	Alfresa : Financial Results Summary for the Third Quarter Ended December 31, 2025	PU
10/02	Alfresa : Briefing on Business Results for the Third Quarter of the Fiscal Year Ending March 2026(April - December 2025) （946KB） PDF	PU
05/02	Alfresa : Notice Regarding Alliance Between Alfresa Corporation and Choraku Choju K.K. to Eliminate Social Isolation and Extend Healthy Life Expectancies	PU
03/02	Alfresa : Notice Regarding Achievement of ISO 9001 Certification by Shikoku Alfresa Corporation	PU
15/01	Alfresa : Notice Regarding the Transfer of Businesses from Remedia Co., Ltd. to Ark Medical Solutions Inc. to Expand the Latter’s CRO Business	PU
15/01	Alfresa : Notice Regarding an Alliance Between Alfresa Corporation and BELLSYSTEM24, Inc. to Offer D-REACH, an Outsourcing-Based Information Provision Activity Support Service for Pharmaceutical Manufacturers	PU
09/01	Alfresa : Onclusion of an Agreement Between Alfresa Corporation and Osaka Prefecture Regarding the Operation of Disaster-Support Container Pharmacies to Support Said Prefecture’s Medical Care Provision Systems	PU
24/12	Alfresa : Notice Regarding Strategic Partnership Agreement Between Cell Resources Corporation and ENCell Co., Ltd.	PU
11/12	Alfresa : Pharma Corporation Acquires Kurumin Certification from the Minister of Health, Labour and Welfare as a Childcare Support Company	PU
01/12	Alfresa : Pharma Corporation Increases Solar Power Generation Equipment at Okayama Plant in an Effort to Achieve Carbon Neutrality	PU
25/11	Alfresa : Signing of an Agreement to Establish a Joint Venture for the Manufacture of Biosimilars	PU